First cancer vaccine trial finds jabs ‘weaponise immunse system to attack killer tumours in 48 hours’
A NEW mRNA cancer vaccine can reprogram the immune system to attack tumours within 48 hours, a study shows.
The first-ever human clinical trial of four adult patients showed the jab helps fight against aggressive and deadly brain tumours.
GettyA NEW mRNA cancer vaccine can reprogram the immune system to attack tumours within 48 hours, a study shows[/caption]It uses similar tech to some Covid vaccines to train the immune system and is also personalised to patients using their own DNA.
Заголовки